CYTO
Altamira Therapeutics Ltd
CYTO
CYTO
Delisted
CYTO was delisted on the 19th of December, 2024.
14 hedge funds and large institutions have $607K invested in Altamira Therapeutics Ltd in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
41% less capital invested
Capital invested by funds: $1.03M → $607K (-$421K)
Holders
14
Holding in Top 10
–
Calls
$117K
Puts
$29K
Top Buyers
| 1 | +$30.5K | |
| 2 | +$19K | |
| 3 | +$16.7K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.32K |
| 5 |
GI
Gradient Investments
Arden Hills,
Minnesota
|
+$1K |
Top Sellers
| 1 | -$28.7K | |
| 2 | -$19K | |
| 3 | -$18K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4K |